Huntington’s disease was long thought to be caused by the slow buildup of a toxic protein, but new research has revealed that it’s actually driven by the expansion of a gene that, at a certain length, triggers quick neuron death.
In this week’s episode of The Top Line, we hear from Steven McCarroll, Ph.D., a Huntington’s disease researcher at the Broad Institute of MIT and Harvard, whose team recently published that research in the journal Cell. McCarroll joins Fierce Biotech’s Darren Incorvaia to dig into the findings, which not only change our understanding of the disease itself, but also open up new avenues for potential treatments.
To learn more about the topics in this episode:

Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones
15:08

Why MRD is becoming central to oncology drug development (Sponsored)
18:38

Behind the headlines of ASCO 2026
29:06